161 related articles for article (PubMed ID: 36142729)
1. AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer.
Agarwal N; Zhou Q; Arya D; Rinaldetti S; Duex J; LaBarbera DV; Theodorescu D
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142729
[TBL] [Abstract][Full Text] [Related]
2. TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Agarwal N; Rinaldetti S; Cheikh BB; Zhou Q; Hass EP; Jones RT; Joshi M; LaBarbera DV; Knott SRV; Cech TR; Theodorescu D
Proc Natl Acad Sci U S A; 2021 Sep; 118(38):. PubMed ID: 34518220
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer.
Liu L; Liu Y; Zhang T; Wu H; Lin M; Wang C; Zhan Y; Zhou Q; Qiao B; Sun X; Zhang Q; Guo X; Zhao G; Zhang W; Huang W
J Exp Clin Cancer Res; 2016 Jan; 35():3. PubMed ID: 26743236
[TBL] [Abstract][Full Text] [Related]
4. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations.
Isenmann S; Cakouros D; Zannettino A; Shi S; Gronthos S
J Bone Miner Res; 2007 Jun; 22(6):897-906. PubMed ID: 17352650
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
[TBL] [Abstract][Full Text] [Related]
6. Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.
Zhuang CL; Fu X; Liu L; Liu YC; Huang WR; Cai ZM
Tumour Biol; 2015 Jul; 36(7):5157-63. PubMed ID: 25775949
[TBL] [Abstract][Full Text] [Related]
7. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
[TBL] [Abstract][Full Text] [Related]
8. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
Rachakonda PS; Hosen I; de Verdier PJ; Fallah M; Heidenreich B; Ryk C; Wiklund NP; Steineck G; Schadendorf D; Hemminki K; Kumar R
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17426-31. PubMed ID: 24101484
[TBL] [Abstract][Full Text] [Related]
10. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells.
Takakura M; Kyo S; Inoue M; Wright WE; Shay JW
Mol Cell Biol; 2005 Sep; 25(18):8037-43. PubMed ID: 16135795
[TBL] [Abstract][Full Text] [Related]
11. Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
Fu WJ; Hong BF; Huang JJ; Xu B; Gao JP; Wang XX; Huang CF
BJU Int; 2005 Oct; 96(6):890-4. PubMed ID: 16153224
[TBL] [Abstract][Full Text] [Related]
12. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
[TBL] [Abstract][Full Text] [Related]
13. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
14. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ
World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide screens identify specific drivers of mutant
Shanmugam R; Ozturk MB; Low JL; Akincilar SC; Chua JYH; Thangavelu MT; Periyasamy G; DasGupta R; Tergaonkar V
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35027447
[TBL] [Abstract][Full Text] [Related]
16. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.
Liu X; Wu G; Shan Y; Hartmann C; von Deimling A; Xing M
Cell Cycle; 2013 May; 12(10):1637-8. PubMed ID: 23603989
[No Abstract] [Full Text] [Related]
17. Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Moehren U; Papaioannou M; Reeb CA; Grasselli A; Nanni S; Asim M; Roell D; Prade I; Farsetti A; Baniahmad A
FASEB J; 2008 Apr; 22(4):1258-67. PubMed ID: 17991730
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
19. hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.
Morozov A; Potoldykova N; Chinenov D; Enikeev M; Glukhov A; Shpikina A; Goryacheva E; Taratkin M; Malavaud B; Enikeev D
Urol Oncol; 2021 Aug; 39(8):498.e21-498.e33. PubMed ID: 33676848
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
